Odyssey Health, Inc.

OTCPK:ODYY Stock Report

Market Cap: US$2.3m

Odyssey Health Management

Management criteria checks 4/4

Odyssey Health's CEO is Mike Redmond, appointed in Dec 2017, has a tenure of 7.08 years. total yearly compensation is $469.22K, comprised of 84.4% salary and 15.6% bonuses, including company stock and options. directly owns 8.79% of the company’s shares, worth $201.03K. The average tenure of the management team and the board of directors is 5.3 years and 3.7 years respectively.

Key information

Mike Redmond

Chief executive officer

US$469.2k

Total compensation

CEO salary percentage84.4%
CEO tenure7.1yrs
CEO ownership8.8%
Management average tenure5.3yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mike Redmond's remuneration changed compared to Odyssey Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Oct 31 2024n/an/a

-US$1m

Jul 31 2024US$469kUS$396k

-US$906k

Apr 30 2024n/an/a

US$11m

Jan 31 2024n/an/a

US$11m

Oct 31 2023n/an/a

-US$4m

Jul 31 2023US$546kUS$396k

-US$6m

Apr 30 2023n/an/a

-US$7m

Jan 31 2023n/an/a

-US$9m

Oct 31 2022n/an/a

-US$9m

Jul 31 2022US$941kUS$360k

-US$8m

Apr 30 2022n/an/a

-US$9m

Jan 31 2022n/an/a

-US$19m

Oct 31 2021n/an/a

-US$18m

Jul 31 2021US$918kUS$325k

-US$17m

Apr 30 2021n/an/a

-US$15m

Jan 31 2021n/an/a

-US$4m

Oct 31 2020n/an/a

-US$4m

Jul 31 2020US$162kUS$162k

-US$4m

Apr 30 2020n/an/a

-US$26m

Jan 31 2020n/an/a

-US$25m

Oct 31 2019n/an/a

-US$25m

Jul 31 2019US$65kUS$18k

-US$23m

Apr 30 2019n/an/a

-US$338k

Jan 31 2019n/an/a

-US$348k

Oct 31 2018n/an/a

-US$489k

Jul 31 2018US$80kUS$80k

-US$483k

Compensation vs Market: Mike's total compensation ($USD469.22K) is about average for companies of similar size in the US market ($USD647.72K).

Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.

CEO

Mike Redmond (63 yo)

7.1yrs

Tenure

US$469,219

Compensation

Mr. Joseph Michael Redmond, also known as Mike, served as President of Oragenics, Inc. since December 28, 2023 until December 16, 2024 and also served as its Interim Principal Executive Officer since Febru...

Leadership Team

NamePositionTenureCompensationOwnership
Joseph Redmond
Chairman7.1yrsUS$469.22k8.79%
$ 201.0k
Christine Farrell
CFO & Secretary5.8yrsUS$293.22k0.10%
$ 2.4k
Greg Gironda
COO & Director2.2yrsno datano data
Michael Contarino
Head of Product Development4.9yrsno datano data

5.3yrs

Average Tenure

64yo

Average Age

Experienced Management: ODYY's management team is seasoned and experienced (5.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Joseph Redmond
Chairman7.1yrsUS$469.22k8.79%
$ 201.0k
Greg Gironda
COO & Directorless than a yearno datano data
Ricky Richardson
Independent Director3.7yrsUS$38.98k0%
$ 0
Bob Arnot
Member of Scientific Advisory Board3.7yrsno datano data
Jerome Casey
Independent Director5.3yrsUS$38.98k0%
$ 0
Dallas Hack
Member of Scientific Advisory Board3.8yrsno datano data
James Kelly
Member of Scientific Advisory Board3.8yrsno datano data
James Linder
Member of Military Advisory Board2.8yrsno datano data
Paul Toolan
Member of Military Advisory Board2.8yrsno datano data
Timothy Szymanski
Member Of Military Advisory Board2.8yrsno datano data

3.7yrs

Average Tenure

63yo

Average Age

Experienced Board: ODYY's board of directors are considered experienced (3.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/15 05:42
End of Day Share Price 2025/01/14 00:00
Earnings2024/10/31
Annual Earnings2024/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Odyssey Health, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution